Lung Diseases
Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

Latest Articles on Lung Diseases

Lung Diseases
100-year anniversary
In 1921, Boehringer Ingelheim set out with a vision to transform the world of respiratory care. 2021 marks the company looks back on 100 years of pushing the boundaries in scientific innovation.

Lung Diseases
Finding the right inhaler for you
Contact your healthcare professional about your inhaler options

Lung Diseases
An Overview of Respiratory
Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
Downloads
Respiratory Research and Development Timeline
Respimat Fact Sheet
Related Press Releases

February 06, 2020